Condition
Pediatric Solid Tumors clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Pediatric Solid Tumors clinical trials that are recruiting, at sites in 4 countries (most in United States (2), Japan (1), South Korea (1)). By phase: Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 4Countries
Newest Pediatric Solid Tumors clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Adaptive Proton Therapy for Pediatric Solid Tumors and Hodgkin Lymphoma | — | Memphis, Tennessee | Recruiting | Apr 7, 2026 |
| Understanding the tumor microenvironment in children's solid tumors to improve adoptive cell therapy | — | Pavia, Pavia | Recruiting | Nov 20, 2025 |
| Improving mental health and quality of life for young cancer survivors and their caregivers | — | Goyang-si, Gyonggi-do and 2 other locations | Recruiting | May 14, 2025 |
| Testing GAIA-102 for difficult-to-treat pediatric cancers | Phase 1 | Fukuoka, Fukuoka | Recruiting | Nov 8, 2022 |
| Molecular analysis of pediatric solid tumors | — | Memphis, Tennessee | Recruiting | Jan 15, 2010 |
All recruiting trials (5)
-
Adaptive Proton Therapy for Pediatric Solid Tumors and Hodgkin Lymphoma
This study tests a regular imaging approach to see if proton therapy plans for children with solid tumors or Hodgkin lymphoma should be updated during treatment.
-
Understanding the tumor microenvironment in children's solid tumors to improve adoptive cell therapy
We will analyze tumor samples from children with solid tumors to see if features of the tumor environment can help guide better adoptive T cell therapy.
-
Improving mental health and quality of life for young cancer survivors and their caregivers
This study is testing whether personalized counseling and education can improve mental health and quality of life for young cancer survivors and their caregivers during the transition from treatment to recovery.
-
Testing GAIA-102 for difficult-to-treat pediatric cancers
This study is testing a new treatment called GAIA-102 for children with tough-to-treat cancers to see if it’s safe and how much of it they should get.
-
Molecular analysis of pediatric solid tumors
This study is trying to understand the genetic and molecular features of different childhood solid tumors to find better ways to treat these tough cancers.
Related topics
Quick answers
How many Pediatric Solid Tumors clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in United States (2 trials), Japan (1 trial), South Korea (1 trial), Italy (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.